NuGEN Announces Co-Marketing Agreement with Qiagen

NuGEN Technologies, Inc. has announced that it has entered into a co-marketing agreement with Qiagen to create a series of joint applications for RNA amplification and analysis.

The agreement will provide researchers with complete solutions for isolation, amplification, fragmentation and labeling of RNA for research purposes as well as for molecular diagnostics.

"We are always seeking new partners with complementary technologies who share our vision of providing our customers complete solutions for their RNA research, especially for small and complex samples," said Sue Pandey, vice president of commercial operations for NuGEN.

"This agreement represents a major step in our strategy of partnering with industry and technology leaders in life sciences."

"We believe Qiagen's recognized expertise and capabilities in preanalytical sample preparation and its reputation for highest quality and reliability will provide enormous value to our customers around the world who are using NuGEN's Ovation™ Systems for amplification."